Last reviewed · How we verify
albuterol aerosol by HFA MDI
Albuterol works by stimulating the beta-2 adrenergic receptors in the lungs, causing bronchodilation and relaxation of bronchial smooth muscle.
Albuterol works by stimulating the beta-2 adrenergic receptors in the lungs, causing bronchodilation and relaxation of bronchial smooth muscle. Used for Maintenance and relief of bronchospasm in asthma and in COPD, Prevention of bronchospasm during exercise.
At a glance
| Generic name | albuterol aerosol by HFA MDI |
|---|---|
| Sponsor | Teva Branded Pharmaceutical Products R&D, Inc. |
| Drug class | Beta-2 adrenergic agonist |
| Target | Beta-2 adrenergic receptor |
| Modality | Small molecule |
| Therapeutic area | Respiratory |
| Phase | Phase 3 |
Mechanism of action
This leads to an increase in airway diameter, making it easier to breathe for individuals with asthma or chronic obstructive pulmonary disease (COPD). The effects of albuterol are rapid and can last for several hours.
Approved indications
- Maintenance and relief of bronchospasm in asthma and in COPD
- Prevention of bronchospasm during exercise
Common side effects
- Tremors
- Nervousness
- Headache
- Dizziness
- Palpitations
Key clinical trials
- Bronchoprovocation Study to Demonstrate the Pharmacodynamic Bioequivalence of Albuterol Sulfate HFA Inhalation Aerosol (E.Q. 90 mcg of Albuterol Base/Inh) of Macleods Pharmaceuticals Ltd (PHASE3)
- Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma (PHASE3)
- Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: